{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:21:00Z","timestamp":1761744060748},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00345-014-1460-9","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T01:53:43Z","timestamp":1418090023000},"page":"685-689","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?"],"prefix":"10.1007","volume":"33","author":[{"given":"Ferdinando","family":"Fusco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Arcaniolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Creta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Piccinocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Arpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Laringe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Piccinocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Verze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mangiapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"issue":"4","key":"1460_CR1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0302-2838(02)00354-8","volume":"42","author":"KM Verhamme","year":"2002","unstructured":"Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, Begaud B, Berges R, Borkowski A, Chappel CR, Costello A, Dobronski P, Farmer RD, Jim\u00e9nez Cruz F, Jonas U, MacRae K, Pientka L, Rutten FF, van Schayck CP, Speakman MJ, Sturkenboom MC, Tiellac P, Tubaro A, Vallencien G, Vela Navarrete R (2002) Triumph Pan European Expert Panel. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care\u2014the Triumph project. Eur Urol 42(4):323\u2013328","journal-title":"Eur Urol"},{"key":"1460_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","volume":"170","author":"AUA practice guidelines committee","year":"2003","unstructured":"AUA practice guidelines committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: diagnosis and treatment recommendations. J Urol 170:530\u2013547","journal-title":"J Urol"},{"issue":"1","key":"1460_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N\u2019Dow J, Nordling J, de la Rosette JJ, European Association of Urology (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118\u2013140","journal-title":"Eur Urol"},{"issue":"1","key":"1460_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","volume":"57","author":"CG Roehrborn","year":"2010","unstructured":"Roehrborn CG, Siami P, Barkin J, Dami\u00e3o R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F, CombAT Study Group (2010) The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 57(1):123\u2013131","journal-title":"Eur Urol"},{"issue":"12","key":"1460_CR5","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1111\/j.1743-6109.2008.01001.x","volume":"5","author":"F Erdemir","year":"2008","unstructured":"Erdemir F, Harbin A, Hellstrom WJ (2008) 5-Alpha reductase inhibitors and erectile dysfunction: the connection. J Sex Med 5(12):2917\u20132924","journal-title":"J Sex Med"},{"issue":"1","key":"1460_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/14740338.2013.742885","volume":"12","author":"S Gur","year":"2013","unstructured":"Gur S, Kadowitz PJ, Hellstrom WJ (2013) Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation. Expert Opin Drug Saf 12(1):81\u201390","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"1460_CR7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.ijir.3901540","volume":"19","author":"A Seftel","year":"2007","unstructured":"Seftel A, Rosen R, Kuritzky L (2007) Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications. Int J Impot Res 19(4):386\u2013392","journal-title":"Int J Impot Res"},{"key":"1460_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2006.06026.x","volume":"8","author":"AL Burnett","year":"2006","unstructured":"Burnett AL (2006) The role of nitric oxide in erectile dysfunction: implications for medical therapy. J Clin Hypertens 8:53\u201362","journal-title":"J Clin Hypertens"},{"key":"1460_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0090-4295(99)80249-0","volume":"46","author":"P Napalkov","year":"1995","unstructured":"Napalkov P, Maisonneuve P, Boyle P (1995) Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Urology 46:41\u201346","journal-title":"Urology"},{"issue":"25","key":"1460_CR10","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD McConnell","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349(25):2387\u20132398","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"1460_CR11","first-page":"S122","volume":"12","author":"KT McVary","year":"2006","unstructured":"McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manag Care 12(5 Suppl):S122\u2013S128","journal-title":"Am J Manag Care"},{"issue":"4","key":"1460_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11934-009-0044-5","volume":"10","author":"AV Sarma","year":"2009","unstructured":"Sarma AV, Kellogg Parsons J (2009) Diabetes and benign prostatic hyperplasia: emerging clinical connections. Curr Urol Rep 10(4):267\u2013275","journal-title":"Curr Urol Rep"},{"key":"1460_CR13","doi-asserted-by":"crossref","unstructured":"Stamatiou K, Lardas M, Kostakos E, Koutsonasios V, Michail E (2009) The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review. Adv Urol 1\u20133. doi: 10.1155\/2009\/818965","DOI":"10.1155\/2009\/818965"},{"issue":"2","key":"1460_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00345-006-0062-6","volume":"24","author":"M Lekili","year":"2006","unstructured":"Lekili M, M\u00fcezzino\u011flu T, Uyanik BS, B\u00fcy\u00fcksu C (2006) Serum lipid levels in benign prostatic hyperplasia. World J Urol 24(2):210\u2013213","journal-title":"World J Urol"},{"key":"1460_CR15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0302-2838(03)00198-2","volume":"44","author":"GL Andriole","year":"2003","unstructured":"Andriole GL, Kirby R (2003) Safety and tolerability of the dual 5-alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. Eur Urol 44:82\u201388","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-014-1460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1460-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:40:18Z","timestamp":1559036418000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-014-1460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s00345-014-1460-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}